Alzheimer's Disease & Dementia

Risk of Alzheimer dementia after androgen deprivation therapy

Risk of Alzheimer dementia after androgen deprivation therapy

By

A recent cohort study evaluated the risk of developing Alzheimer dementia after ADT in 16,888 men with prostate cancer, 14.2% of whom were treated with ADT.

The bravery of people with dementia

The bravery of people with dementia

By

Facing dementia with strength and courage can inspire and comfort patients' families.

Minimal benzodiazepine use associated with slightly higher risk of dementia

Minimal benzodiazepine use associated with slightly higher risk of dementia

By

Patients administered low doses of benzodiazepines have an elevated risk of dementia and Alzheimer's disease compared with patients who received higher doses.

Prostate cancer treatment linked to Alzheimer's risk

Prostate cancer treatment linked to Alzheimer's risk

By

Patients treated with androgen deprivation therapy had a 1.88-times increased rate of developing Alzheimer's disease.

Modifiable risk factors for Alzheimer's disease

Modifiable risk factors for Alzheimer's disease

By

Research reveals that focus on diet, mental health, and lifestyle may help lower the number of new cases of Alzheimer's disease.

MIND diet help may lower Alzheimer risk

MIND diet help may lower Alzheimer risk

The MIND diet combines the Mediterranean diet with the DASH diet, both of which call for high consumption of fruits, vegetables, and fish.

Running may lower Alzheimer-related mortality risk

Running may lower Alzheimer-related mortality risk

Patients who ran more than 15.3 miles per week had a 40% reduced risk of dying from Alzheimer disease.

Is a blood test that can predict Alzheimer disease on the way?

Is a blood test that can predict Alzheimer disease on the way?

Researchers have identified 10 proteins in the blood that may be predictors of Alzheimer disease.

Deep brain stimulation may improve memory in Alzheimer's patients

Deep brain stimulation may improve memory in Alzheimer's patients

A pilot study reports deep brain stimulation targeted at the nucleus basalis of Meynert improved or stabilized memory in Alzheimer's patients.

Midlife diabetes, HTN linked to cognitive decline

Midlife diabetes, HTN linked to cognitive decline

Midlife onset of diabetes and hypertension each may contribute to cognitive impairment later in life.

Blood test may predict Alzheimer disease

Blood test may predict Alzheimer disease

Scientists who tested seniors found that the test detected almost all of those who would develop problems.

Celexa cuts Alzheimer's agitation, but safety questionable

Celexa cuts Alzheimer's agitation, but safety questionable

Cognitive and cardiac adverse effects may limit the antidepressant's use for this purpose.

New tests to detect early Alzheimer disease

New tests to detect early Alzheimer disease

By

Two new cognitive screening assessment tools appear to be useful additions to the arsenal of Alzheimer testing.

Estradiol, diabetes up dementia risk in women

Estradiol, diabetes up dementia risk in women

Women with both diabetes and elevated estradiol levels were 14 times more likely to develop new-onset dementia.

DDT exposure linked to Alzheimer risk

DDT exposure linked to Alzheimer risk

By

Exposure to the banned pesticide DDT may play a role in the development of Alzheimer disease.

No benefit with Alzheimer drugs in phase 3 trials

No benefit with Alzheimer drugs in phase 3 trials

No improvement in cognition in four randomized trials involving bapineuzumab and solanezumab.

CVD linked to cognitive decline in older women

CVD linked to cognitive decline in older women

Highest risks for myocardial infarction, other vascular disease. No link for a-fib, heart failure.

Role transition 101: Facing a parent's end of life

Role transition 101: Facing a parent's end of life

By

Opening the door to real emotional engagement from a family member's illness can make it hard to close when it comes to patients.

USPSTF: Evidence insufficient for routine dementia screening

USPSTF: Evidence insufficient for routine dementia screening

Despite lack of evidence on benefits of routine screening, clinicians should remain alert to early signs or symptoms of cognitive impairment.

AD lowers risk of cancer in older people

AD lowers risk of cancer in older people

By

Older persons with AD have a reduced risk for developing cancer.

Famous faces test IDs young-onset dementia

Famous faces test IDs young-onset dementia

A simple test called the Northwestern University Famous Faces (NUFFACE) Test may aid in diagnosing primary progressive aphasia.

Use a laser to get patients walking

Use a laser to get patients walking

A simple technique gets patients with Parkinson disease and dementia to ambulate.

U.S. dementia costs to surpass $200 billion annually

U.S. dementia costs to surpass $200 billion annually

In 2010, dementia-associated costs ranged from $159 billion to $215 billion, and are projected to increase 80% per adult by 2040.

Obama announces plans to map the human brain

Obama announces plans to map the human brain

10-year BRAIN initiative aims to find new ways to treat, cure and prevent neurological disorders.

Imaging guidelines issued for Alzheimer disease

Imaging guidelines issued for Alzheimer disease

By

Alzheimer's Association issues first guidelines for PET scanning in Alzheimer disease diagnosis.

Alzheimer disease projected to affect 13.8 million in U.S. by 2050

Alzheimer disease projected to affect 13.8 million in U.S. by 2050

The incidence of Alzheimer disease (AD) dementia among U.S. seniors is expected to triple during next 40 years.

Kidney decline linked with cognitive decline

Kidney decline linked with cognitive decline

By

Changes in renal functioning over time were associated with changes in global cognitive ability, verbal episodic memory and abstract reasoning.

Treating a paranoiac for dementia

Treating a paranoiac for dementia

What is the recommended treatment for patients diagnosed with dementia who are suffering with paranoia and/or hallucinations?

When to advise palliative care

When to advise palliative care

When do patients benefit most from palliative care consults?

Relapse risk high after discontinuing Alzheimer treatment

Relapse risk high after discontinuing Alzheimer treatment

More attention to risk-benefit ratio of antipsychotics for patients with AD needed to inform federal nursing home regulations.

Sign Up for Free e-newsletters